Andrographolide attenuated MCT-induced HSOS via regulating NRF2-initiated mitochondrial biogenesis and antioxidant response

Cell Biol Toxicol. 2023 Dec;39(6):3269-3285. doi: 10.1007/s10565-023-09832-7. Epub 2023 Oct 11.

Abstract

Hepatic sinusoidal obstruction syndrome (HSOS) is a death-dealing liver disease with a fatality rate of up to 67%. In the study present, we explored the efficacy of andrographolide (Andro), a diterpene lactone from Andrographis Herba, in ameliorating the monocrotaline (MCT)-induced HSOS and the underlying mechanism. The alleviation of Andro on MCT-induced rats HSOS was proved by biochemical index detection, electron microscope observation, and liver histological evaluation. Detection of hepatic ATP content, mitochondrial DNA (mtDNA) copy number, and protein expression of nuclear respiratory factor-1 (NRF1) and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) demonstrated that Andro strengthened mitochondrial biogenesis in livers from MCT-treated rats. Chromatin immunoprecipitation assay exhibited that Andro enhanced the occupation of nuclear factor erythroid 2-related factor 2 (NFE2L2, also known as NRF2) in the promoter regions of both PPARGC1A and NRF1. Andro also activated the NRF2-dependent anti-oxidative response and alleviated liver oxidative injury. In Nrf2 knock-out mice, MCT induced more severe liver damage, and Andro showed no alleviation in it. Furthermore, the Andro-activated mitochondrial biogenesis and anti-oxidative response were reduced in Nrf2 knock-out mice. Contrastingly, knocking out Kelch-like ECH-associated protein 1 (Keap1), a NRF2 repressor, reduced MCT-induced liver damage. Results from co-immunoprecipitation, molecular docking analysis, biotin-Andro pull-down, cellular thermal shift assay, and surface plasmon resonance assay showed that Andro hindered the NRF2-KEAP1 interaction via directly binding to KEAP1. In conclusion, our results revealed that NRF2-dependent liver mitochondrial biogenesis and anti-oxidative response were essential for the Andro-provided alleviation of the MCT-induced HSOS. Graphical Headlights: 1. Andro alleviated MCT-induced HSOS via activating antioxidative response and promoting mitochondrial biogenesis. 2. Andro-activated antioxidative response and mitochondrial biogenesis were NRF2-dependent. 3. Andro activated NRF2 via binding to KEAP1.

Keywords: Andrographolide; HSOS; KEAP1; Mitochondrial biogenesis; NRF2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • DNA, Mitochondrial / metabolism
  • Diterpenes* / pharmacology
  • Hepatic Veno-Occlusive Disease* / chemically induced
  • Hepatic Veno-Occlusive Disease* / metabolism
  • Hepatic Veno-Occlusive Disease* / pathology
  • Kelch-Like ECH-Associated Protein 1 / metabolism
  • Mice
  • Mice, Knockout
  • Molecular Docking Simulation
  • Monocrotaline / adverse effects
  • NF-E2-Related Factor 2 / metabolism
  • Organelle Biogenesis
  • Oxidative Stress
  • Rats

Substances

  • Antioxidants
  • Monocrotaline
  • andrographolide
  • NF-E2-Related Factor 2
  • Kelch-Like ECH-Associated Protein 1
  • Diterpenes
  • DNA, Mitochondrial